Claritev (CTEV) 44th Annual J.P. Morgan Healthcare Conference summary

Strategic Vision and Transformation

• Focused on transparency, affordability, and innovation in healthcare, leveraging 40 years of expertise and a broad client base across the care continuum.

• Undertook a major transformation, rebranding, and leadership overhaul, emphasizing clarity, alignment, and focus, with a new management team and structured priorities.

• Strategic roadmap includes brand launches, new products, disciplined execution, and sustained growth through 2030, supported by Vision 2030 transformation program.

• Diversified client and product base, with international expansion and new verticals, aiming to double the addressable market and achieve sustainable, long-term growth.

• Emphasized a disciplined, methodical approach to growth, including major debt restructuring and operational discipline.

Technology and Product Innovation

• Invested heavily in technology modernization, moving to Oracle Cloud, unifying data architecture, and rewriting legacy applications.

• Launched Network Builder and expanded product roadmap with over 30 enhancements and 10 new products planned, focusing on client-driven innovation.

• Integrated acquisitions like BST and BenInsights, enhancing data analytics and employee benefit solutions, including partnerships with Oracle HCM.

• Product suite addresses fragmentation, waste, and inefficiencies in care coordination, distributed across payors, employers, providers, government, channel partners, and international markets.

• Leveraged deep client relationships, proprietary analytics, and business rules to create high barriers to entry and maintain competitive advantage.

Financial Performance and Outlook

• Achieved 7% revenue growth in Q3, with record EBITDA and consistent sequential growth, supported by strong R&D investment (14% of revenue).

• Quarterly revenue and adjusted EBITDA have shown consistent growth from Q1 2023 to Q3 2025.

• Spent $500 million on technology over five years, with $100 million more planned for digital transformation under Vision 2030.

• Revenue per claim up 30% over 12 quarters, driven by healthcare inflation and higher-value claims in ambulatory and behavioral health.

• Targeting leverage reduction starting in 2026, with organic growth and selective, value-creating M&A aligned to core focus.